03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Diabetes
Peter Ueda: no photograph is held, so the academic plate is shown instead.
Academic
Peter Ueda
Assistant professor, Department of Medicine, Karolinska Institute
3
0
0
Sept 2026Oct 2026Nov 2026to date
3
press citations on 1 topic since 2 Sept 2026 · last quoted 2 Sept 2026
02 Quoted on · 1 of 29 topics
Peter Ueda: key facts
- Kind of voice
- Academic
- Role
- Assistant professor, Department of Medicine, Karolinska Institute
- Quoted on
- Diabetes
- Tracked press citations
- 3
- Most recently quoted
- 2 Sept 2026
04 The signal · where Peter Ueda sits on diabetes
Ranked 48= of 100 voices quoted in the press on diabetes, level with 35 others on 3 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Douglas TwenefourClinicianHead of Clinical, Diabetes UK36 - 2
Dr Elizabeth RobertsonSector leaderDirector of Research and Clinical, Diabetes UK20 - 3=
Helen KnightRegulatorDirector of Medicines Evaluation, National Institute for Health and Care Excellence (NICE)15 - 48=Julio Rosenstock, MDAcademicPivotal trial lead investigator at Velocity Clinical Research at Medical City in Dallas3
- 48=Hilary NathanSector leaderDirector of Policy and Communications at Breakthrough T1D3
- 48=Peter UedaAcademicAssistant professor, Department of Medicine, Karolinska Institute3
- 48=
Dr Nick ThomasAcademicAcademic Clinical Lecturer in Diabetes and Endocrinology (also Diabetes Consultant, Royal Devon University Healthcare NHS Foundation Trust), University of Exeter3 - 48=Clair GraingerClinicianDr, Superdrug Online Doctor3
Showing the leaders and the ranks around 48=, of 100 voices · See every voice on the topic →
05 On the record · press
What Peter Ueda has said
By outlet · linked articles
- aol.co.uk1
- ladbible.com1
- mirror.co.uk1
Where Peter Ueda has been quoted
- 01New 'fatal' warning for anyone on dapagliflozin, empagliflozin or canagliflozin - AOLaol.co.uk · 2 Sept 2026
- 02New 'fatal' warning for anyone on dapagliflozin, empagliflozin or canagliflozinmirror.co.uk · 2 Sept 2026
- 03Scientists issue warning over common diabetes drugs that could trigger life-threatening 'attack'ladbible.com · 2 Sept 2026
Verbatim
“Our findings are not primarily about avoiding treatment, but about improving our ability to identify high-risk patients and use these medicines more safely.”
“SGLT2 inhibitors provide medical benefits for many patients. Our findings are not primarily about avoiding treatment, but about improving our ability to identify high-risk patients and use these medicines more safely.”
“SGLT2 inhibitors provide medical benefits for many patients”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.